Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PRECIGEN, INC. Director's Dealing 2013

Aug 7, 2013

32044_dirs_2013-08-07_75378925-dbf9-42c4-b856-39c30d83d2b1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: INTREXON CORP (XON)
CIK: 0001356090
Period of Report: 2013-08-07

Reporting Person: HORNER LARRY D /FA (Director)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 4083 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Option to Purchase Common Stock $2.74 2018-02-20 Common Stock (8571) Direct
Option to Purchase Common Stock $3.29 2019-02-20 Common Stock (2857) Direct
Option to Purchase Common Stock $3.29 2020-06-30 Common Stock (2857) Direct
Option to Purchase Common Stock $5.91 2021-03-07 Common Stock (2857) Direct
Option to Purchase Common Stock $7.12 2021-12-02 Common Stock (8571) Direct
Option to Purchase Common Stock $7.12 2022-03-15 Common Stock (2857) Direct
Option to Purchase Common Stock $9.67 2023-05-28 Common Stock (2857) Direct
Series E Convertible Preferred Stock $ Common Stock (60560) Direct

Footnotes

F1: These options are immediately exercisable.

F2: 2,142 options are exercisable immediately; the remaining 715 options vest on January 1, 2014.

F3: 1,428 options are exercisable immediately; the remaining options vest annually in increments of 714 and 715 on each of January 1, 2014 and 2015, respectively.

F4: 2,142 options are exercisable immediately; the remaining options vest annually in increments of 2,143 on each of December 1, 2013, 2014 and 2015, respectively.

F5: 714 options are exercisable immediately; the remaining options vest annually in increments of 714, 714 and 715 on each of January 1, 2014, 2015 and 2016, respectively.

F6: These options vest annually in increments of 714, 714, 714 and 715 on each of January 1, 2014, 2015, 2016 and 2017, respectively.

F7: The Series E Convertible Preferred Stock is convertible into Common Stock on a 1-for-1.75 basis into the number of shares of Common Stock as shown in column 3 at any time at the holder's election, and automatically upon (i) the closing of the Issuer's firm commitment underwritten initial public offering in the event it results in net proceeds of at least $100,000,000 and (ii) upon the election of the holders of a majority of the then outstanding shares of such series. Upon conversion, all dividends that have accrued with respect to Series E Preferred Stock will convert into shares of Common Stock at the then current fair market value. The Series E Convertible Preferred Stock has no expiration date.